BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 10389587)

  • 41. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies.
    Renshaw AA; Cartagena N; Schenkman RH; Derhagopian RP; Gould EW
    Am J Clin Pathol; 2001 Jul; 116(1):92-6. PubMed ID: 11447758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation between type and grade of ductal carcinoma in situ and concomitant invasive ductal carcinoma of the breast.
    Rudnicka L; Stachura J
    Pol J Pathol; 2000; 51(3):137-43. PubMed ID: 11247396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytologic features of ductal carcinoma in situ in fine-needle aspiration of the breast mirror the histopathologic growth pattern heterogeneity and grading.
    Sauer T; Lømo J; Garred O; Naess O
    Cancer; 2005 Feb; 105(1):21-7. PubMed ID: 15593325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
    Carder PJ; Garvican J; Haigh I; Liston JC
    Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mammary lesions diagnosed as "papillary" by aspiration biopsy: 70 cases with follow-up.
    Simsir A; Waisman J; Thorner K; Cangiarella J
    Cancer; 2003 Jun; 99(3):156-65. PubMed ID: 12811856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
    Renshaw AA; Derhagopian RP; Martinez P; Gould EW
    Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
    Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
    Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast disease: a primer on diagnosis and management.
    Drukker BH
    Int J Fertil Womens Med; 1997; 42(5):278-87. PubMed ID: 9406832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytologic features of ductal carcinoma in situ.
    Theocharous C; Greenberg ML
    Diagn Cytopathol; 1996 Dec; 15(5):367-73. PubMed ID: 8989536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carcinoma In Situ Involving Sclerosing Adenosis: Seeking the Salient Histological Characteristics to Prevent Overdiagnosis.
    Cui X; Wei S
    Ann Clin Lab Sci; 2017 Sep; 47(5):529-534. PubMed ID: 29066477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Noninvasive carcinoma of the breast presenting in adenosis.
    Oberman HA; Markey BA
    Mod Pathol; 1991 Jan; 4(1):31-5. PubMed ID: 1850517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis.
    Rakha EA; Gandhi N; Climent F; van Deurzen CH; Haider SA; Dunk L; Lee AH; Macmillan D; Ellis IO
    Am J Surg Pathol; 2011 Aug; 35(8):1093-103. PubMed ID: 21753694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microinvasive carcinoma of the breast: a diagnosis in search of a definition.
    Schnitt SJ
    Adv Anat Pathol; 1998 Nov; 5(6):367-72. PubMed ID: 10095878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of proteoglycan versican in in situ breast lesions: relations between stromal changes, histotype, and invasion.
    Canavese G; Candelaresi G; Castellano I; Mano MP
    Pathol Res Pract; 2011 Feb; 207(2):97-103. PubMed ID: 21185131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Nodular sclerosing adenosis (adenosis tumor) of the breast. An immunohistologic study particularly in reference to the relationship with radial cicatrix and to the differential diagnosis with tubular carcinoma].
    Lanzafame S
    Pathologica; 1989; 81(1073):251-66. PubMed ID: 2641538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spectral morphometric characterization of breast carcinoma cells.
    Barshack I; Kopolovic J; Malik Z; Rothmann C
    Br J Cancer; 1999 Mar; 79(9-10):1613-9. PubMed ID: 10188915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Monoclonal antibodies to the proteins of intermediate filaments and of basement membranes in the differential diagnosis of certain forms of human breast tumors].
    Gel'shteĭn VI; Chipysheva TA; Ermilova VD; Liubimov AV
    Arkh Patol; 1990; 52(9):12-8. PubMed ID: 1702969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In situ lobular neoplasia of the breast with marked myoepithelial proliferation.
    Shousha S
    Histopathology; 2011 Jun; 58(7):1081-5. PubMed ID: 21707709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carcinoma in situ in sclerosing adenosis of the breast: an immunocytochemical study.
    Eusebi V; Collina G; Bussolati G
    Semin Diagn Pathol; 1989 May; 6(2):146-52. PubMed ID: 2762670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mammary ductal carcinoma in situ with microinvasion.
    Silver SA; Tavassoli FA
    Cancer; 1998 Jun; 82(12):2382-90. PubMed ID: 9635531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.